Scientists at the UK’s University of Oxford said Tuesday they’ve found that a low-cost, common drug significantly reduced 6,000-patient trial. Dexamethasone, a steroid, cut down deaths in patients receiving ventilation by one-third, they said. In patients getting oxygen treatment, it reduced deaths by one-fifth.-related deaths in a
The drug didn’t appear to help patients who aren’t receiving respiratory support for, the disease caused by the coronavirus.
Britain’s National Health Service will work the drug into its standard COVID-19 treatment starting Tuesday, according to UK health secretary Matt Hancock. The government has 200,000 doses available now, having stockpiled it for months.
“The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients,” Professor Peter Horby, one of the lead researchers, said in a release. “Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”
It comes as more thanhave been confirmed globally, according to tracking numbers from Johns Hopkins University, and less than a week since US cases . As of Tuesday morning, there have been over 437,000 deaths globally, more than 116,000 of which are in the US. A vaccine may not arrive .
If you’re concerned that you might have contracted the coronavirus, the CDCto help you decide whether to get a test. You may have it if you’re suffering from coughing or shortness of breath. You could also be infected if you have two of the following symptoms:
- Repeated shaking with chills
- Muscle pain
- Sore throat
- New loss of taste or smell
Here’s how to find aand how the .
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.